Curon Biotech

Allinaire Therapeutics is a biopharmaceutical company based in Beachwood, OH, specializing in the development of innovative therapeutics for cardiopulmonary diseases. Founded in 2016 by BioMotiv and managed by Advent Life Sciences, the company focuses on the advancement of humanized anti-endothelial monocyte activating polypeptide II (EMAP II) monoclonal antibodies as potential disease-modifying treatments for conditions such as pulmonary arterial hypertension (PAH), chronic obstructive pulmonary disease (COPD), and viral-induced acute lung injury. Under the scientific guidance of founders Matthias Clauss, PhD, and Irina Petrache, MD, along with their colleagues at Indiana University and National Jewish Health, Allinaire Therapeutics and its network of preclinical and clinical scientists have demonstrated the crucial role of EMAP II in various cardiopulmonary diseases, impacting apoptosis, cell injury, endothelial cell function, and inflammation.Generated from the website

NeuroWave Systems Inc, based in Cleveland, OH, is a pioneering company dedicated to developing innovative brain monitoring and drug delivery medical devices. Powered by cutting-edge signal processing and control engineering technologies, their vision is to automate anesthesia for improved and safer patient care. NeuroWave Systems is proud to offer the NeuroSENSE Monitor, the latest generation of brain monitors that provide simultaneous independent indices of anesthetic effect for each side of the brain. This unique bilateral brain function monitor offers clinicians greater insight into the brain of anesthetized or sedated patients, helping them detect brain function asymmetry and make optimal decisions for safer and improved patient care.Generated from the website

Neoproteomics Inc is a Cleveland-based company specializing in advanced proteomics research and development. With a focus on Japan, they offer a range of innovative solutions and technologies for protein analysis, including the identification and characterization of proteins, protein-protein interactions, and post-translational modifications. Utilizing cutting-edge techniques and state-of-the-art equipment, Neoproteomics Inc provides comprehensive proteomic services to academic institutions, pharmaceutical companies, and biotechnology firms. Their expertise in proteomics enables them to contribute to advancements in drug discovery, personalized medicine, and biomarker identification, making them a trusted partner in the field of proteomics research.Generated from the website